Obesidad y Cáncer
OBECAN
Aristotle University of Thessaloniki
Salónica, GreciaPublicaciones en colaboración con investigadores/as de Aristotle University of Thessaloniki (2)
2023
-
Peptide Polyagonists for the Treatment of Nonalcoholic Fatty Liver Disease
Current Pharmaceutical Design
2019
-
Semaglutide as a promising antiobesity drug
Obesity Reviews, Vol. 20, Núm. 6, pp. 805-815